-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
NEUROONE MEDICAL TECHNOLOGIES Corp annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2011 to Q4 2023.
- NEUROONE MEDICAL TECHNOLOGIES Corp Net Cash Provided by (Used in) Operating Activities for the quarter ending December 31, 2023 was -$3.81M, a 9.08% decline year-over-year.
- NEUROONE MEDICAL TECHNOLOGIES Corp annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$11M, a 14.6% increase from 2023.
- NEUROONE MEDICAL TECHNOLOGIES Corp annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$12.9M, a 71.4% decline from 2022.
- NEUROONE MEDICAL TECHNOLOGIES Corp annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$7.52M, a 12.6% increase from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)